rome1’s details
| symbol | subject | date & time | rating |
|
|
And when they expire ....then what? Someone mentioned the stock was possibly shorted...that would be genius but what brokerage allows shorting on a penny stock? Does it not have to be a minimum of a dollar plus? It will take a year or maybe two f... |
12/21/2012 8:48:47 AM |
3 |
|
|
Well, after having my head handed to me by V.SSS a few years ago ...I swore I would never ride another FDA / phase result on a junior biotech...I will only buy and hold but always sell before the results are finally released. In the one in a mi... |
12/20/2012 10:36:49 AM |
|
|
|
Hehe...I would hold off on that Bentley down payment....focus on your goal of turkey for Christmas. That is a fairly healthy ignore rating on your profile...I see a lot of people have been taking your advice with a grain of salt. Talk later...you... |
11/23/2012 2:22:03 PM |
|
|
|
OK fine... I purchased at 17 cents...probably the only time I can ever say that I bought any stock at the absolute lowest. I am very happy with the return to date.... I love the bul@sh^&tters around here and stockhouse as whole...saying how m... |
11/23/2012 10:52:27 AM |
4 |
|
|
The share price is relatively high at this point.... I believe the top line results could come back positive but if they do not...the share price will drop like a rock. This is just a fact. For a company with zero revenue and still some time ... |
11/22/2012 7:47:32 AM |
4 |
|
|
May be time to pay attention to this little sh$t kicker again? They need to partner one would think...the 2 mill in the bank wont last forever...although the overhead is pretty minimal. It may be that the majority holder is trying to average down... |
10/24/2012 11:01:35 AM |
1 |
|
|
With my luck to zero...hehe...we will see....just sit back and relax as there won't be much going on unti top line results are released... They are well funded...fast tracked with the FDA...SPA in hand...and a phase 2/3 which is being carried... |
9/13/2012 10:43:46 AM |
4 |
|
|
September 11, 2012 Allon’s CEO presenting at 2012 Rodman and Renshaw Global Conference VANCOUVER, B.C. — Allon Therapeutics Inc. (TSX: NPC) President and CEO Gordon McCauley will present an update of the Company’s business p... |
9/11/2012 8:43:18 AM |
5 |
|
|
"So from what I read have the three stages of clinical trials not started yet?" Nope...5 - 10 years start to finish, once they do.... |
5/24/2012 3:21:45 PM |
4 |
|
No additional content to display.
Stockhouse.com: Taking
it to the street
